| 000 | 01687 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517090221.0 | ||
| 264 | 0 | _c20170117 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1941-837X | ||
| 024 | 7 |
_a10.3111/13696998.2015.1131704 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Nanxin | |
| 245 | 0 | 0 |
_aComparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis. _h[electronic resource] |
| 260 |
_bJournal of medical economics _c2016 |
||
| 300 |
_a414-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xeconomics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEverolimus _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHealth Expenditures _xstatistics & numerical data |
| 650 | 0 | 4 |
_aHealth Services _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Claim Review _xstatistics & numerical data |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aReceptor, ErbB-2 |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aHao, Yanni | |
| 700 | 1 | _aKoo, Valerie | |
| 700 | 1 | _aFang, Anna | |
| 700 | 1 | _aPeeples, Miranda | |
| 700 | 1 | _aKageleiry, Andrew | |
| 700 | 1 | _aWu, Eric Q | |
| 700 | 1 | _aGuérin, Annie | |
| 773 | 0 |
_tJournal of medical economics _gvol. 19 _gno. 4 _gp. 414-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3111/13696998.2015.1131704 _zAvailable from publisher's website |
| 999 |
_c25881492 _d25881492 |
||